HomePHAT • NASDAQ
add
Phathom Pharmaceuticals Inc
Previous close
$10.54
Day range
$10.30 - $10.99
Year range
$6.07 - $17.02
Market cap
637.45M USD
Avg Volume
654.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 1.91M | — |
Operating expense | 71.44M | 137.52% |
Net income | -82.85M | -119.10% |
Net profit margin | -4.33K | — |
Earnings per share | -1.11 | -24.72% |
EBITDA | -69.74M | -133.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 322.23M | 148.68% |
Total assets | 356.50M | 147.55% |
Total liabilities | 505.00M | 115.62% |
Total equity | -148.50M | — |
Shares outstanding | 58.54M | — |
Price to book | -4.15 | — |
Return on assets | -45.40% | — |
Return on capital | -49.72% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -82.85M | -119.10% |
Cash from operations | -69.02M | -73.99% |
Cash from investing | -40.00K | 81.31% |
Cash from financing | 9.90M | -29.65% |
Net change in cash | -59.16M | -129.20% |
Free cash flow | -54.92M | -61.41% |
About
Founded
2018
Headquarters
Website
Employees
452